| Identification | Back Directory | [Name]
6,7,8,9,10,11,12,13,14,15,16,17,24,25,26,27,28,29,30,31,32,33-docosahydro-35,37-dimethyl-5,34:18,23-diethenodibenzo[b,r][1,5,16,20]tetraazacyclotriacontine-23,34-diium diacetate | [CAS]
3785-44-2 | [Synonyms]
R-199
Salvisol
bisdequalinium acetate
Bisdequalinium diacetate
N1,N1'-Decamethylene-N4,N4'-Decamethylene-bis-(4-aminoquinaldinium)diacetate
6,7,8,9,10,11,12,13,14,15,16,17,24,25,26,27,28,29,30,31,32,33-docosahydro-35,37-dimethyl-5,34:18,23-diethenodibenzo[b,r][1,5,16,20]tetraazacyclotriacontine-23,34-diium diacetate | [EINECS(EC#)]
223-252-5 | [Molecular Formula]
C42H61N4O2+ | [MDL Number]
MFCD00866769 | [MOL File]
3785-44-2.mol | [Molecular Weight]
653.98 |
| Hazard Information | Back Directory | [Uses]
Salvizol (Bisdequalinium diacetate) is a chemotherapeutic agent with a broad spectrum of bactericidal activity, effective in the apical third of root canals. Salvizol possesses the ability to dissolve organic dentin matrix, facilitating mineralization and tubule exposure. Salvizol maintains a neutral pH, ensuring biological compatibility while exhibiting significant cleansing potency. | [Definition]
ChEBI: Bisdequalinium diacetate is an aminoquinoline. | [References]
[1] New chemotherapeutic agent for root canal treatment. A preliminary electron microscopic study on an in vivo and in vitro endodontically treated tooth DOI:10.1016/0030-4220(78)90204-9 |
|
|